Quick Answer
MAIA Biotechnology, Inc. reported Stockholders Equity of $2.38 million for fiscal year 2025.
MAIA Biotechnology, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.38M | -34.6% |
| 2024 | $3.63M | +661.2% |
| 2023 | $477.5K | -94.4% |
| 2022 | $8.51M | -7.3% |
| 2021 | $9.18M | +668.0% |
| 2020 | -$1.62M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $41.7K | -97.4% | -98.9% |
| June 30, 2025 | $3.88M | +22.6% | -21.6% |
| March 31, 2025 | $4.94M | +185.7% | +36.0% |
| December 31, 2024 | $3.63M | +661.2% | +124.6% |
| September 30, 2024 | $1.62M | -41.1% | -48.8% |
| June 30, 2024 | $3.16M | -54.0% | +154.8% |
| March 31, 2024 | -$5.76M | -213.4% | -1307.3% |
| December 31, 2023 | $477.5K | -94.4% | -82.6% |
- MAIA Biotechnology, Inc. showed a decrease of -34.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, MAIA Biotechnology, Inc.’s stockholders equity has grown by 247.0% (from -$1.62 million to $2.38 million).
- The most recent figure is from MAIA Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: